University of Montana & Montana State University Tech Transfer

Sorry, we couldn't find any posts. Please try a different search.

Damage-Reducing Stroke Drug from University of Montana Spinoff, Sinapis Pharma, Moving To Human Trials

Our whole goal is to try to create startup companies that stay here in Montana,” he said. “This has been fun. I get as excited about the business of science as the science of science. It’s exciting to have the chance to develop something that actually gets into the clinic and changes lives.”

Flower power – Critics question stimulus funds spent on science research at the University of Montana

"The general population I don’t think understands how important university-based basic research is to the economic well-being and the future of this country," Dwyer says.

Ohio University makes a bundle on sale of company School’s share in sale of Diagnostic Hybrids could total $41 million

"This is really a story about Ohio University wanting to assist its faculty in its research and help invest in that research."

University of Montana VISION 2009 – Research, Innovation & Scholarship

Campus research efforts now expend more than $67 million annually.

University of Montana develops software, Global Information Gatherer, designed to aid college students

“Students have so much information to manage and incorporate from many resources. We want to help them integrate technology in the most beneficial way.”

University of Montana Hires New Technology Transfer Director. Dr. Joe Fanguy

“It’s an honor to have been selected for this great leadership opportunity within The University of Montana’s growing research community,” said Fanguy, who earned a doctorate in biophysical chemistry with an emphasis in biotechnology instrumentation from Mississippi State University.

University of Montana Research Could Provide Effective Treatment for Stroke and Traumatic Brain Injury – Sinapis Pharma

“The University of Montana is now at a critical point, where we can really capitalize on this technology and move it into the public domain where people can actually benefit.”

University of Montana Spinoff, Sinapis Pharma, Closes Series ‘A’ Financing

Sinapis Pharma has discovered and is developing a novel therapeutic approach to neuronal protection using its intravenous methamphetamine technology.